Zelira Therapeutics LTD has launched its first US-based product line called RAF FIVE. This new line of products includes five dermatologist-approved acne-fighting creams and treatments.
RAF FIVE consists of a gel cleanser, a spot treatment, an SPF hydrating lotion, an acne treatment, and special acne pads. Infused with skin-rejuvenating ingredients such as hyaluronic acid, niacinamide, glycerine, and peptides - the ingredients were thoughtfully chosen to help eliminate and prevent acne breakouts.
The RAF FIVE line features Zelira Therapeutics' patent-pending acne treatment Zylorama, which was developed by dermatologist Dr. Karyn Grossman. Zylorama uses a blend of CBD, salicylic acid, and botanical compounds to help reduce bacteria build-up in the skin's pores. The product has been rigorously studied and has shown impressive results after seven days of treatment.
Dermatologist-Designed Acne Treatments
Zelira Therapeutics Launches a New Skincare Line in the US
Trend Themes
-
Dermatologist-designed Skincare — Dermatologist-designed skincare lines are emerging as a disruptive innovation opportunity in the skincare industry.
-
Cbd-infused Skincare — CBD-infused skincare products are gaining popularity as a new trend in the healthcare industry.
-
Personalized Acne Treatments — Personalized acne treatments are emerging as a disruptive innovation opportunity in the beauty industry.
Industry Implications
-
Skincare Industry — The skincare industry can leverage dermatologist-designed skincare lines to gain a competitive edge
-
Healthcare Industry — The healthcare industry can look into innovative CBD-infused skincare products as a new revenue stream.
-
Beauty Industry — The beauty industry can pursue personalized skincare treatment options to meet customer demand.